Inactive Instrument

Press Releases Neothetics Inc Nasdaq

Stocks

US64066G1013

Pharmaceuticals

Press Releases

18/05	Evofem Reports First Quarter 2026 Financial Results and Provides Business Update	BU
27/04	Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa	BU
12/03	Evofem Reports Fifth Consecutive Year of Net Sales Growth	BU
21/11	Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE	PR
14/11	Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update	PR
11/11	Evofem Biosciences : EVFM Investor Presentation Nov 2025	PU
01/25/01	Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates	PR
13/25/13	EVFM Investor Presentation: 12 September 2025	PU
10/25/10	Evofem Biosciences : Special Meeting of Stockholders	PU
05/25/05	Evofem Biosciences : EVFM Corporate Update 5 September 2025	PU
19/25/19	FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis	PR
14/25/14	Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update	PR
31/25/31	Evofem Biosciences : AditXt Weekly Update 6.6.2025 - Transcript	PU
24/25/24	Evofem Biosciences : EVFM Corporate Update 23 June 2025	PU
23/25/23	Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store	PR
28/25/28	Evofem Biosciences : EVFM Corporate Overview 28 May 2025	PU
21/25/21	Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1	PR
15/25/15	Evofem Reports First Quarter 2025 Financial Results and Provides Business Update	PR
02/25/02	Evofem Biosciences : EVFM Corporate Overview 01 May, 2025	PU
22/25/22	Evofem Biosciences : EVFM Presentation at Emerging Growth Conference April 2025	PU
18/25/18	Evofem Biosciences : EVFM Corporate Overview April 9, 2025	PU
14/25/14	Evofem Biosciences to Present at Emerging Growth Conference	PR
24/25/24	Evofem Biosciences : Investor Presentation March 2025	PU
26/25/26	Evofem Biosciences : EVFM Investor Presentation February 2025	PU
13/25/13	Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO	PR